| Literature DB >> 25229474 |
Nikos D Koromilas1, Georgia Ch Lainioti1, Chrisostomi Gialeli1, Despoina Barbouri1, Katerina B Kouravelou2, Nikos K Karamanos1, George A Voyiatzis3, Joannis K Kallitsis1.
Abstract
Novel Carbon Nanotube-Entities:
Mesh:
Substances:
Year: 2014 PMID: 25229474 PMCID: PMC4167694 DOI: 10.1371/journal.pone.0107029
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Schematic illustration of the functionalization of CNTs with SSNa moieties (A) and the introduction of quaternized ammonium groups (B).
Functionalization of CNTs with ATRP initiator groups.
| Material | TGA weight loss | Number of modified carbon atoms to Thin-MWCNTs per 1000 C |
| MWCNTs-OH | 6 | 8 |
| Thin-MWCNTs-OH | 11 | 15 |
| MWCNTs-Init | 2 | 6 |
| Thin-MWCNTs-Init | 3 | 9 |
compared to pristine CNTs.
Figure 2Schematic illustration of the functionalization of CNTs-OH with P(AA12-co-VBCHAM).
Figure 3SEM-EDS analysis of Thin-MWCNTs-Init.
Polymerization of sodium styrene sulfonate (SSNa) onto the CNT-Init surface.
| Material | Μol Init/mol CuBr/mol PMDETA/mol SSNa | TGA weight loss | TGA weight loss | Μn, TGA
| Monomer units/initiator site (for 50%–100% fuctionalization) |
| MWCNTs-g-PSSNa | 1/1.8/1.8/180 | 4 | 18 | 1802 | 3–6 |
| Τhin MWCNTs-g-PSSNa | 1/4/4/133 | 3.5 | 11 | 2650 | 2–4 |
mol of initiator = [(TGA weight loss of Thin-MWCNTs-Init - TGA weight loss of Thin-MWCNTs-ΟΗ)*mass of Thin-MWCNTs-Init]/(molecular weight of imported group*100).
compared to CNTs-Init.
compared to PSSNa.
Μn,TGA = theoretically TGA weight loss of Thin MWCNTs-g-PSSNa/[(1- theoretically TGA weight loss of Thin-MWCNTs-g-PSSNa)*(mol of initiator/g of initiator)].
Figure 4TGA curves of pristine Thin-MWCNTs and Thin-MWCNTs-g-PSSNa, as well as Τhin-MWCNTs-g-PSSAmC16 (A), and Τhin MWCNTs-g-PSSPhC16 (B).
TGA curves of the copolymers of PSSNa and PSSPhC16 are also shown.
Figure 51Η-NMR spectra of the copolymer P(AA12-co-VBC) (A) and the quaternized copolymer P(AA12-co-VBCHAM) (B) and FT-IR spectra of the above copolymers (C).
Figure 6TGA curves of pristine Thin-MWCNTs, Thin-MWCNTs-ΟH, Thin-MWCNTs-g-P(ΑΑ12-co-VBCHAM) and the quaternized P(ΑΑ12-co-VBCHAM).
Figure 7Effects of pristine and hydroxyl decorated CNTs on lung fibroblasts cells proliferation for a 24 h incubation period.
(A) . Pristine MWCNTs and . MWCNTs-OH and (B) . Pristine Thin-MWCNTs and . Thin-MWCNTs-OH. A range of concentrations from 0.125 µg/mL to 25 µg/mL was assayed. The results are expressed as mean ±SD of three separate experiments in triplicate. Statistically significant differences were evaluated using the ANOVA test. Statistically significant differences among the 1% PF-127 treated and control cells are shown by (#) (p≤0.05). Statistically significant differences among the CNTs-treated and 1% PF-127 are shown by (*) (p≤0.05), (**) (p≤0.01) and (***) (p≤0.001).
Figure 8Effects of surfactant and pristine CNTs on lung cancer cells microtubules.
Immunofluorescence staining was performed for α-tubulin (red) and nuclei (blue) in A549 cells after permeabilization. Data are representative of three independent experiments. Panel A. ( ) Untreated Control cells and () 1% PF-127. Panel B. MWCNTs () 25 µg/mL and () 0.125 µg/mL. Panel C. Thin- MWCNTs () 25 µg/mL and () 0.125 µg/mL.
Figure 9Effects of SSNa decorated CNTs on lung fibroblasts cells proliferation for a 24h incubation period.
(A) MWCNTs-g-PSSNa and (B) Thin-MWCNTs-g-PSSNa. A range of concentrations from 0.125 µg/mL to 25 µg/mL was assayed. The results are expressed as mean ±SD of three separate experiments in triplicate. Statistically significant differences were evaluated using the ANOVA test. Statistically significant differences among the 1% PF-127 treated and control cells are shown by (#) (p≤0.05). Statistically significant differences among the CNTs-treated and 1% PF-127 are shown by (*) (p≤0.05), (**) (p≤0.01) and (***) (p≤0.001).
Figure 10Effects of PSSPhC16 and PSSAmC16 decorated CNTs on lung fibroblasts cells proliferation for a 24 h incubation period.
(A) MWCNTs-g-PSSAmC16 and (B) . Thin-MWCNTs-g-PSSPhC16 and . Thin-MWCNTs-g-PSSAmC16. A range of concentrations from 0.125 µg/mL to 25 µg/mL was assayed. The results are expressed as mean ±SD of three separate experiments in triplicate. Statistically significant differences were evaluated using the ANOVA test. Statistically significant differences among the 1% PF-127 treated and control cells are shown by (#) (p≤0.05). Statistically significant differences among the CNTs-treated and 1% PF-127 are shown by (*) (p≤0.05), (**) (p≤0.01) and (***) (p≤0.001).
Figure 11Effect of PSSPhC16 and PSSAmC16 decorated CNTs on lung cancer cells microtubules.
Immunofluorescence staining was performed for α-tubulin (red) and nuclei (blue) in A549 cells after permeabilization. Data are representative of three independent experiments. Panel A. MWCNTs-g-PSSAmC16 () 25 µg/mL and () 0.125 µg/mL. Panel B. Thin-MWCNTs-g-PSSAPhC16 () 25 µg/mL and () 0.125 µg/mL. Panel C. Thin-MWCNTs-g-PSSAmC16 () 25 µg/mL and () 0.125 µg/mL.
Figure 12Effects of MWCNTs-g-P(AA12-co-VCHAM) on lung fibroblasts cells proliferation for a 24 h incubation period.
A range of concentrations from 0.125 µg/mL to 25 µg/mL was assayed. The results are expressed as mean ±SD of three separate experiments in triplicate.
Figure 13Effect of P(AA12-co-VBCHAM) decorated CNTs on lung cancer cells microtubules.
Immunofluorescence staining was performed for α-tubulin (red) and nuclei (blue) in A549 cells after permeabilization. Data are representative of three independent experiments. Panel A. MWCNTs-g-P(AA12-co-VCHAM) () 25 µg/mL and () 0.125 µg/mL. Panel B. Thin-MWCNTs-g-P(AA12-co-VCHAM) () 25 µg/mL and () 0.125 µg/mL.